Difference between revisions of "Team:CPU CHINA"
Ser Archer (Talk | contribs) |
Ser Archer (Talk | contribs) |
||
| Line 115: | Line 115: | ||
.anniu { | .anniu { | ||
position: relative; | position: relative; | ||
| − | top: | + | top: 42% !important; |
transition: top 0.2s; | transition: top 0.2s; | ||
margin: 0 0 0 -50px; | margin: 0 0 0 -50px; | ||
| Line 155: | Line 155: | ||
</div> | </div> | ||
</div> | </div> | ||
| + | |||
<div id="anniu1" class="anniu" style="top:150px;"> | <div id="anniu1" class="anniu" style="top:150px;"> | ||
<center> | <center> | ||
| − | <a href="# | + | <a href="#words"> |
<img src="https://static.igem.org/mediawiki/2017/7/7e/T--HZAU-China--arrow.gif"> | <img src="https://static.igem.org/mediawiki/2017/7/7e/T--HZAU-China--arrow.gif"> | ||
</a> | </a> | ||
| Line 164: | Line 165: | ||
| − | <div id="words" style="position:relative;display:none;width:80%;top: | + | <div id="words" style="position:relative;display:none;width:80%;top:53%;margin-left:10%;font-size:2.5rem;line-height:2.5;"> |
<h1 style="position:relative;width:90%;margin-left:5%;top:28%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1> | <h1 style="position:relative;width:90%;margin-left:5%;top:28%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1> | ||
<h4 style="font-size:2.5rem;line-height:2.5">MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.</h4> | <h4 style="font-size:2.5rem;line-height:2.5">MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.</h4> | ||
Revision as of 16:14, 6 November 2018
